EquityZen Growth Technology Fund LLC - Series 772
Raised
$431K
Investors
24
Min Invest
$10,001
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 772 is a Delaware pooled investment fund filing under Regulation D Rule 506(b), managed by EquityZen Advisors with oversight from Assure Fund Management II. This amended filing reports $431K raised from 24 investors with a $10K minimum investment. The entity is part of the EquityZen platform, which operates nearly 1,900 pre-IPO investment vehicles.
This pre-IPO fund exemplifies the retail-accessible SPV model common in secondary share platforms, using 506(b) exemption to allow non-accredited participation and a $10K minimum to enable fractional access to late-stage private company equity. The investor count and raise size are consistent with typical EquityZen series vehicles targeting concentrated exposure to individual growth-stage companies.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
